ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

NBSE NeuBase Therapeutics Inc

0.4101
0.0051 (1.26%)
May 06 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
NeuBase Therapeutics Inc NBSE NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.0051 1.26% 0.4101 18:55:46
Open Price Low Price High Price Close Price Previous Close
0.3766 0.36 0.418 0.4101 0.405
more quote information »

Recent News

Date Time Source Heading
5/06/202406:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
4/05/202415:05GLOBENeuBase Therapeutics Announces Receipt of Notice from Nasdaq
3/07/202415:01EDGAR2Form 8-K - Current report
2/23/202415:01EDGAR2Form 8-K - Current report
1/26/202407:00EDGAR2Form 8-K - Current report
1/17/202405:15EDGAR2Form 8-K - Current report
12/28/202306:00EDGAR2Form 8-K - Current report
12/28/202305:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12/22/202305:15EDGAR2Form 8-K - Current report
11/27/202308:00GLOBEPsychemedics Corporation Appoints Daniella Mehalik as VP -..
11/09/202315:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/06/202316:00EDGAR2Form 8-K - Current report
10/20/202306:30EDGAR2Form 8-K - Current report
10/18/202307:00EDGAR2Form 8-K - Current report
9/29/202315:10EDGAR2Form 8-K - Current report
9/20/202319:42EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
9/20/202316:28EDGAR2Form SC 13D/A - General statement of acquisition of..
9/18/202315:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/18/202315:20EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
9/18/202315:17EDGAR2Form 8-K - Current report
9/14/202305:03EDGAR2Form SC 13D/A - General statement of acquisition of..
9/11/202316:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/08/202306:00GLOBENeuBase Therapeutics Issues Statement Regarding Filing By..
9/07/202316:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/06/202309:00PRNUSSYMETRYX CORPORATION ACQUIRES 20% STOCK IN NEUBASE
8/31/202310:50EDGAR2Form SC 13D - General statement of acquisition of beneficial..
8/14/202315:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/11/202305:18EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
8/11/202305:15EDGAR2Form DEF 14A - Other definitive proxy statements
8/10/202316:13EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
8/04/202315:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/03/202306:05EDGAR2Form 8-K - Current report
8/01/202315:45EDGAR2Form PRE 14A - Other preliminary proxy statements
7/31/202315:10EDGAR2Form 8-K - Current report
7/28/202305:03EDGAR2Form S-1 - General form for registration of securities under..
6/30/202315:21EDGAR2Form 8-K - Current report
6/30/202307:42EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
6/30/202307:41EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]

Your Recent History

Delayed Upgrade Clock